Century Therapeutics(IPSC)
$1.68+-0.13 (+0.00%)
IPSC
Century Therapeutics financials statements
$1.68
At close:+-0.13 (+0.00%)
Want to see IPSC full AI Analyst Report?
Century Therapeutics (IPSC) Financial Statements
297 Followers
Century Therapeutics Financial Overview
Century Therapeutics's market cap is currently $304.21M. The company's EPS TTM is $-1.04; its P/E ratio is -1.61; Century Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 109.16M | $ 6.59M | $ 2.23M | $ 5.20M | $ 0.00 |
| Gross Profit | $ 96.06M | $ 6.59M | $ 2.23M | $ 5.20M | $ -4.58M |
| Operating Income | $ -15.04M | $ -138.14M | $ -146.55M | $ -133.83M | $ -94.88M |
| EBITDA | $ 3.45M | $ -111.47M | $ -121.21M | $ -121.20M | $ -90.76M |
| Net Income | $ -9.58M | $ -126.57M | $ -136.67M | $ -130.93M | $ -95.82M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 117.11M | $ 189.29M | $ 172.74M | $ 315.50M | $ 222.88M |
| Total Assets | $ 223.70M | $ 353.22M | $ 360.69M | $ 486.54M | $ 437.38M |
| Total Debt | $ 43.56M | $ 53.83M | $ 48.17M | $ 49.41M | $ 25.12M |
| Net Debt | $ -18.29M | $ -4.61M | $ 847.00K | $ -34.85M | $ -31.33M |
| Total Liabilities | $ 64.77M | $ 191.85M | $ 175.94M | $ 183.81M | $ 41.14M |
| Stockholders' Equity | $ 158.94M | $ 161.36M | $ 184.75M | $ 302.74M | $ 396.24M |
| Cash Flow | |||||
| Free Cash Flow | $ -104.72M | $ -110.29M | $ -102.08M | $ -16.55M | $ -133.97M |
| Operating Cash Flow | $ -103.88M | $ -110.14M | $ -88.35M | $ 14.05M | $ -89.00M |
| Investing Cash Flow | $ 107.50M | $ 47.48M | $ 61.13M | $ -13.13M | $ -298.34M |
| Financing Cash Flow | $ 173.00K | $ 74.56M | $ -9.72M | $ 27.16M | $ 417.77M |
Currency in USD
